Rare
lephants
Screener
Toggle theme
NewAmsterdam Pharma Company N.V.
NAMS
·
Healthcare, Drug Manufacturers - General, Netherlands
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
Shares Outstanding
Compare
←
5Y
10Y
MAX
→
Shares Outstanding
Chart
Table
Fiscal Year
Shares Outstanding
FY2023
82.2M
FY2024
94.4M
FY2025
118.4M
FY2026
115.0M
Download CSV
